Publication Results

Generate Report

Add publications by marking their checkboxes, or

Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia.

Tang H,  Jiang L,  Stolzenberg-Solomon RZ,  Arslan AA,  Beane Freeman LE,  Bracci PM,  Brennan P,  Canzian F,  Du M,  Gallinger S,  Giles GG,  Goodman PJ,  Kooperberg C,  Le Marchand L,  Neale RE,  Shu XO,  Visvanathan K,  White E,  Zheng W,  Albanes D,  Andreotti G,  Babic A,  Bamlet WR,  Berndt SI,  Blackford A,  Bueno-de-Mesquita B,  Buring JE,  Campa D,  Chanock SJ,  Childs E,  Duell EJ,  Fuchs C,  Gaziano JM,  Goggins M,  Hartge P,  Hassam MH,  Holly EA,  Hoover RN,  Hung RJ,  Kurtz RC,  Lee IM,  Malats N,  Milne RL,  Ng K,  Oberg AL,  Orlow I,  Peters U,  Porta M,  Rabe KG,  Rothman N,  Scelo G,  Sesso HD,  Silverman DT,  Thompson IM Jr,  Tjønneland A,  Trichopoulou A,  Wactawski-Wende J,  Wentzensen N,  Wilkens LR,  Yu H,  Zeleniuch-Jacquotte A,  Amundadottir LT,  Jacobs EJ,  Petersen GM,  Wolpin BM,  Risch HA,  Chatterjee N,  Klein AP,  Li D,  Kraft P,  Wei P
Cancer Epidemiol Biomarkers Prev 2020 Sep;29(9):1784-1791
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32546605
PMC ID: PMC7483330 [available on March 01, 2021]

Reproductive and hormonal factors and bladder cancer risk: a prospective study and meta-analysis.

Xu X,  Mo Q,  Shen H,  Wang S,  Liu B
Aging (Albany NY) 2020 Jul 6;12(14):14691-14698
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32629427
PMC ID: PMC7425497

Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls.

Wang Y,  Gorlova OY,  Gorlov IP,  Zhu M,  Dai J,  Albanes D,  Lam S,  Tardon A,  Chen C,  Goodman GE,  Bojesen SE,  Landi MT,  Johansson M,  Risch A,  Wichmann HE,  Bickeboller H,  Christiani DC,  Rennert G,  Arnold SM,  Brennan P,  Field JK,  Shete S,  Le Marchand L,  Melander O,  Brunnstrom H,  Liu G,  Hung RJ,  Andrew AS,  Kiemeney LA,  Zienolddiny S,  Grankvist K,  Johansson M,  Caporaso NE,  Woll PJ,  Lazarus P,  Schabath MB,  Aldrich MC,  Stevens VL,  Ma H,  Jin G,  Hu Z,  Amos CI,  Shen H
Cancer Epidemiol Biomarkers Prev 2020 Jul;29(7):1423-1429
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32277007
PMC ID: not available

Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Huang JY,  Larose TL,  Luu HN,  Wang R,  Fanidi A,  Alcala K,  Stevens VL,  Weinstein SJ,  Albanes D,  Caporaso NE,  Purdue MP,  Ziegler RG,  Freedman ND,  Lan Q,  Prentice RL,  Pettinger M,  Thomson CA,  Cai Q,  Wu J,  Blot WJ,  Shu XO,  Zheng W,  Arslan AA,  Zeleniuch-Jacquotte A,  Le Marchand L,  Wilkens LR,  Haiman CA,  Zhang X,  Stampfer MJ,  Han J,  Giles GG,  Hodge AM,  Severi G,  Johansson M,  Grankvist K,  Langhammer A,  Hveem K,  Xiang YB,  Li HL,  Gao YT,  Visvanathan K,  Ueland PM,  Midttun Ø,  Ulvi A,  Buring JE,  Lee IM,  Sesso HD,  Gaziano JM,  Manjer J,  Relton C,  Koh WP,  Brennan P,  Johansson M,  Yuan JM
Int J Cancer 2020 May 1;146(9):2394-2405
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31276202
PMC ID: PMC6960354 [available on January 05, 2021]

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer.

Archambault AN,  Su YR,  Jeon J,  Thomas M,  Lin Y,  Conti DV,  Win AK,  Sakoda LC,  Lansdorp-Vogelaar I,  Peterse EFP,  Zauber AG,  Duggan D,  Holowatyj AN,  Huyghe JR,  Brenner H,  Cotterchio M,  Bézieau S,  Schmit SL,  Edlund CK,  Southey MC,  MacInnis RJ,  Campbell PT,  Chang-Claude J,  Slattery ML,  Chan AT,  Joshi AD,  Song M,  Cao Y,  Woods MO,  White E,  Weinstein SJ,  Ulrich CM,  Hoffmeister M,  Bien SA,  Harrison TA,  Hampe J,  Li CI,  Schafmayer C,  Offit K,  Pharoah PD,  Moreno V,  Lindblom A,  Wolk A,  Wu AH,  Li L,  Gunter MJ,  Gsur A,  Keku TO,  Pearlman R,  Bishop DT,  Castellví-Bel S,  Moreira L,  Vodicka P,  Kampman E,  Giles GG,  Albanes D,  Baron JA,  Berndt SI,  Brezina S,  Buch S,  Buchanan DD,  Trichopoulou A,  Severi G,  Chirlaque MD,  Sánchez MJ,  Palli D,  Kühn T,  Murphy N,  Cross AJ,  Burnett-Hartman AN,  Chanock SJ,  de la Chapelle A,  Easton DF,  Elliott F,  English DR,  Feskens EJM,  FitzGerald LM,  Goodman PJ,  Hopper JL,  Hudson TJ,  Hunter DJ,  Jacobs EJ,  Joshu CE,  Küry S,  Markowitz SD,  Milne RL,  Platz EA,  Rennert G,  Rennert HS,  Schumacher FR,  Sandler RS,  Seminara D,  Tangen CM,  Thibodeau SN,  Toland AE,  van Duijnhoven FJB,  Visvanathan K,  Vodickova L,  Potter JD,  Männistö S,  Weigl K,  Figueiredo J,  Martín V,  Larsson SC,  Parfrey PS,  Huang WY,  Lenz HJ,  Castelao JE,  Gago-Dominguez M,  Muñoz-Garzón V,  Mancao C,  Haiman CA,  Wilkens LR,  Siegel E,  Barry E,  Younghusband B,  Van Guelpen B,  Harlid S,  Zeleniuch-Jacquotte A,  Liang PS,  Du M,  Casey G,  Lindor NM,  Le Marchand L,  Gallinger SJ,  Jenkins MA,  Newcomb PA,  Gruber SB,  Schoen RE,  Hampel H,  Corley DA,  Hsu L,  Peters U,  Hayes RB
Gastroenterology 2020 Apr;158(5):1274-1286.e12
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31866242
PMC ID: PMC7103489 [available on April 01, 2021]

Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease.

Eldridge RC,  Wentzensen N,  Pfeiffer RM,  Brinton LA,  Hartge P,  Guillemette C,  Kemp TJ,  Pinto LA,  Trabert B
Cancer Causes Control 2020 Apr;31(4):309-320
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32100190
PMC ID: PMC7472689 [available on April 01, 2021]

Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk.

Khankari NK,  Banbury BL,  Borges MC,  Haycock P,  Albanes D,  Arndt V,  Berndt SI,  Bézieau S,  Brenner H,  Campbell PT,  Casey G,  Chan AT,  Chang-Claude J,  Conti DV,  Cotterchio M,  English DR,  Figueiredo JC,  Giles GG,  Giovannucci EL,  Gunter MJ,  Hampe J,  Hoffmeister M,  Hopper JL,  Jenkins MA,  Joshi AD,  Marchand LL,  Lemire M,  Li CI,  Li L,  Lindblom A,  Martín V,  Moreno V,  Newcomb PA,  Offit K,  Pharoah PDP,  Rennert G,  Sakoda LC,  Schafmayer C,  Schmit SL,  Slattery ML,  Song M,  Thibodeau SN,  Ulrich CM,  Weinstein SJ,  White E,  Win AK,  Wolk A,  Woods MO,  Wu AH,  Cai Q,  Denny JC,  Edwards TL,  Murff HJ,  Gruber SB,  Peters U,  Zheng W
Cancer Epidemiol Biomarkers Prev 2020 Apr;29(4):860-870
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32051193
PMC ID: PMC7125012

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses.

Murphy N,  Carreras-Torres R,  Song M,  Chan AT,  Martin RM,  Papadimitriou N,  Dimou N,  Tsilidis KK,  Banbury B,  Bradbury KE,  Besevic J,  Rinaldi S,  Riboli E,  Cross AJ,  Travis RC,  Agnoli C,  Albanes D,  Berndt SI,  Bézieau S,  Bishop DT,  Brenner H,  Buchanan DD,  Onland-Moret NC,  Burnett-Hartman A,  Campbell PT,  Casey G,  Castellví-Bel S,  Chang-Claude J,  Chirlaque MD,  de la Chapelle A,  English D,  Figueiredo JC,  Gallinger SJ,  Giles GG,  Gruber SB,  Gsur A,  Hampe J,  Hampel H,  Harrison TA,  Hoffmeister M,  Hsu L,  Huang WY,  Huyghe JR,  Jenkins MA,  Keku TO,  Kühn T,  Kweon SS,  Le Marchand L,  Li CI,  Li L,  Lindblom A,  Martín V,  Milne RL,  Moreno V,  Newcomb PA,  Offit K,  Ogino S,  Ose J,  Perduca V,  Phipps AI,  Platz EA,  Potter JD,  Qu C,  Rennert G,  Sakoda LC,  Schafmayer C,  Schoen RE,  Slattery ML,  Tangen CM,  Ulrich CM,  van Duijnhoven FJB,  Van Guelpen B,  Visvanathan K,  Vodicka P,  Vodickova L,  Vymetalkova V,  Wang H,  White E,  Wolk A,  Woods MO,  Wu AH,  Zheng W,  Peters U,  Gunter MJ
Gastroenterology 2020 Apr;158(5):1300-1312.e20
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31884074
PMC ID: PMC7152801

Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.

Stolzenberg-Solomon R,  Derkach A,  Moore S,  Weinstein SJ,  Albanes D,  Sampson J
Gut 2020 Feb 14
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32060129
PMC ID: not available

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer.

McNabb S,  Harrison TA,  Albanes D,  Berndt SI,  Brenner H,  Caan BJ,  Campbell PT,  Cao Y,  Chang-Claude J,  Chan A,  Chen Z,  English DR,  Giles GG,  Giovannucci EL,  Goodman PJ,  Hayes RB,  Hoffmeister M,  Jacobs EJ,  Joshi AD,  Larsson SC,  Le Marchand L,  Li L,  Lin Y,  Männistö S,  Milne RL,  Nan H,  Newton CC,  Ogino S,  Parfrey PS,  Petersen PS,  Potter JD,  Schoen RE,  Slattery ML,  Su YR,  Tangen CM,  Tucker TC,  Weinstein SJ,  White E,  Wolk A,  Woods MO,  Phipps AI,  Peters U
Int J Cancer 2020 Feb 1;146(3):861-873
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31037736
PMC ID: PMC6819207 [available on February 01, 2021]

Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis.

Papadimitriou N,  Dimou N,  Tsilidis KK,  Banbury B,  Martin RM,  Lewis SJ,  Kazmi N,  Robinson TM,  Albanes D,  Aleksandrova K,  Berndt SI,  Timothy Bishop D,  Brenner H,  Buchanan DD,  Bueno-de-Mesquita B,  Campbell PT,  Castellví-Bel S,  Chan AT,  Chang-Claude J,  Ellingjord-Dale M,  Figueiredo JC,  Gallinger SJ,  Giles GG,  Giovannucci E,  Gruber SB,  Gsur A,  Hampe J,  Hampel H,  Harlid S,  Harrison TA,  Hoffmeister M,  Hopper JL,  Hsu L,  María Huerta J,  Huyghe JR,  Jenkins MA,  Keku TO,  Kühn T,  La Vecchia C,  Le Marchand L,  Li CI,  Li L,  Lindblom A,  Lindor NM,  Lynch B,  Markowitz SD,  Masala G,  May AM,  Milne R,  Monninkhof E,  Moreno L,  Moreno V,  Newcomb PA,  Offit K,  Perduca V,  Pharoah PDP,  Platz EA,  Potter JD,  Rennert G,  Riboli E,  Sánchez MJ,  Schmit SL,  Schoen RE,  Severi G,  Sieri S,  Slattery ML,  Song M,  Tangen CM,  Thibodeau SN,  Travis RC,  Trichopoulou A,  Ulrich CM,  van Duijnhoven FJB,  Van Guelpen B,  Vodicka P,  White E,  Wolk A,  Woods MO,  Wu AH,  Peters U,  Gunter MJ,  Murphy N
Nat Commun 2020 Jan 30;11(1):597
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 32001714
PMC ID: PMC6992637

DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.

Pardini B,  Corrado A,  Paolicchi E,  Cugliari G,  Berndt SI,  Bezieau S,  Bien SA,  Brenner H,  Caan BJ,  Campbell PT,  Casey G,  Chan AT,  Chang-Claude J,  Cotterchio M,  Gala M,  Gallinger SJ,  Haile RW,  Harrison TA,  Hayes RB,  Hoffmeister M,  Hopper JL,  Hsu L,  Huyghe J,  Jenkins MA,  Le Marchand L,  Lin Y,  Lindor NM,  Nan H,  Newcomb PA,  Ogino S,  Potter JD,  Schoen RE,  Slattery ML,  White E,  Vodickova L,  Vymetalkova V,  Vodicka P,  Gemignani F,  Peters U,  Naccarati A,  Landi S
Int J Cancer 2020 Jan 15;146(2):363-372
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31209889
PMC ID: PMC7301215 [available on January 15, 2021]

A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.

Zhong J,  Jermusyk A,  Wu L,  Hoskins JW,  Collins I,  Mocci E,  Zhang M,  Song L,  Chung CC,  Zhang T,  Xiao W,  Albanes D,  Andreotti G,  Arslan AA,  Babic A,  Bamlet WR,  Beane-Freeman L,  Berndt S,  Borgida A,  Bracci PM,  Brais L,  Brennan P,  Bueno-de-Mesquita B,  Buring J,  Canzian F,  Childs EJ,  Cotterchio M,  Du M,  Duell EJ,  Fuchs C,  Gallinger S,  Gaziano JM,  Giles GG,  Giovannucci E,  Goggins M,  Goodman GE,  Goodman PJ,  Haiman C,  Hartge P,  Hasan M,  Helzlsouer KJ,  Holly EA,  Klein EA,  Kogevinas M,  Kurtz RJ,  LeMarchand L,  Malats N,  Männistö S,  Milne R,  Neale RE,  Ng K,  Obazee O,  Oberg AL,  Orlow I,  Patel AV,  Peters U,  Porta M,  Rothman N,  Scelo G,  Sesso HD,  Severi G,  Sieri S,  Silverman D,  Sund M,  Tjønneland A,  Thornquist MD,  Tobias GS,  Trichopoulou A,  Van Den Eeden SK,  Visvanathan K,  Wactawski-Wende J,  Wentzensen N,  White E,  Yu H,  Yuan C,  Zeleniuch-Jacquotte A,  Hoover R,  Brown K,  Kooperberg C,  Risch HA,  Jacobs EJ,  Li D,  Yu K,  Shu XO,  Chanock SJ,  Wolpin BM,  Stolzenberg-Solomon RZ,  Chatterjee N,  Klein AP,  Smith JP,  Kraft P,  Shi J,  Petersen GM,  Zheng W,  Amundadottir LT
J Natl Cancer Inst 2020 Jan 9
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 31917448
PMC ID: not available

Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.

Tang D,  Zhao YC,  Qian D,  Liu H,  Luo S,  Patz EF,  Moorman PG,  Su L,  Shen S,  Christiani DC,  Glass C,  Gao W,  Wei Q
Mol Carcinog 2020 Jan;59(1):104-115
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31713888
PMC ID: PMC7481022

Processed Meat Intake and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort.

Xu X
Cancer Epidemiol Biomarkers Prev 2019 Dec;28(12):1993-1997
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31533945
PMC ID: not available

Mitochondrial somatic mutations and the lack of viral genomic variation in recurrent respiratory papillomatosis.

Hao Y,  Ruiz R,  Yang L,  Neto AG,  Amin MR,  Kelly D,  Achlatis S,  Roof S,  Bing R,  Kannan K,  Brown SM,  Pei Z,  Branski RC
Sci Rep 2019 Nov 12;9(1):16625
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31719597
PMC ID: PMC6851396

Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.

Abdel-Rahman O
World J Surg 2019 Nov;43(11):2927-2933
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31332492
PMC ID: not available

Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.

Tarney CM,  Wang G,  Bateman NW,  Conrads KA,  Zhou M,  Hood BL,  Loffredo J,  Tian C,  Darcy KM,  Hamilton CA,  Casablanca Y,  Lokshin A,  Conrads TP,  Maxwell GL
Am J Obstet Gynecol 2019 Nov;221(5):472.e1-472.e10
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31279844
PMC ID: not available

Pre-diagnostic body mass index trajectory in relationship to lung cancer incidence and mortality; findings from the PLCO trial.

Abdel-Rahman O
Expert Rev Respir Med 2019 Oct;13(10):1029-1035
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31414914
PMC ID: not available

Prediagnostic BMI and thyroid cancer incidence in the PLCO trial.

Abdel-Rahman O
Future Oncol 2019 Oct;15(30):3451-3456
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31646903
PMC ID: not available

Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.

Ganly I,  Yang L,  Giese RA,  Hao Y,  Nossa CW,  Morris LGT,  Rosenthal M,  Migliacci J,  Kelly D,  Tseng W,  Hu J,  Li H,  Brown S,  Pei Z
Int J Cancer 2019 Aug 1;145(3):775-784
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30671943
PMC ID: PMC6554043

Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Kreimer AR,  Ferreiro-Iglesias A,  Nygard M,  Bender N,  Schroeder L,  Hildesheim A,  Robbins HA,  Pawlita M,  Langseth H,  Schlecht NF,  Tinker LF,  Agalliu I,  Smoller SW,  Ness-Jensen E,  Hveem K,  D'Souza G,  Visvanathan K,  May B,  Ursin G,  Weiderpass E,  Giles GG,  Milne RL,  Cai Q,  Blot WJ,  Zheng W,  Weinstein SJ,  Albanes D,  Brenner N,  Hoffman-Bolton J,  Kaaks R,  Barricarte A,  Tjønneland A,  Sacerdote C,  Trichopoulou A,  Vermeulen RCH,  Huang WY,  Freedman ND,  Brennan P,  Waterboer T,  Johansson M
Ann Oncol 2019 Aug 1;30(8):1335-1343
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31185496
PMC ID: PMC6683856

Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings From The PLCO Trial.

Abdel-Rahman O
Clin Genitourin Cancer 2019 Aug;17(4):e837-e844
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31213414
PMC ID: not available

Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.

Landgren O,  Hofmann JN,  McShane CM,  Santo L,  Hultcrantz M,  Korde N,  Mailankody S,  Kazandjian D,  Murata K,  Thoren K,  Ramanathan L,  Dogan A,  Rustad E,  Lu SX,  Akhlaghi T,  Kristinsson SY,  Björkholm M,  Devlin S,  Purdue MP,  Pfeiffer RM,  Turesson I
JAMA Oncol 2019 Jul 18
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31318385
PMC ID: PMC6646992

Dairy Product Consumption and Prostate Cancer Risk in the United States.

Preble I,  Zhang Z,  Kopp R,  Garzotto M,  Bobe G,  Shannon J,  Takata Y
Nutrients 2019 Jul 16;11(7)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31315238
PMC ID: PMC6683061

Deep Learning to Assess Long-term Mortality From Chest Radiographs.

Lu MT,  Ivanov A,  Mayrhofer T,  Hosny A,  Aerts HJWL,  Hoffmann U
JAMA Netw Open 2019 Jul 3;2(7):e197416
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31322692
PMC ID: PMC6646994

Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.

Wang X,  Dai JY,  Albanes D,  Arndt V,  Berndt SI,  Bézieau S,  Brenner H,  Buchanan DD,  Butterbach K,  Caan B,  Casey G,  Campbell PT,  Chan AT,  Chen Z,  Chang-Claude J,  Cotterchio M,  Easton DF,  Giles GG,  Giovannucci E,  Grady WM,  Hoffmeister M,  Hopper JL,  Hsu L,  Jenkins MA,  Joshi AD,  Lampe JW,  Larsson SC,  Lejbkowicz F,  Li L,  Lindblom A,  Le Marchand L,  Martin V,  Milne RL,  Moreno V,  Newcomb PA,  Offitt K,  Ogino S,  Pharoah PDP,  Pinchev M,  Potter JD,  Rennert HS,  Rennert G,  Saliba W,  Schafmayer C,  Schoen RE,  Schrotz-King P,  Slattery ML,  Song M,  Stegmaier C,  Weinstein SJ,  Wolk A,  Woods MO,  Wu AH,  Gruber SB,  Peters U,  White E
Int J Epidemiol 2019 Jun 1;48(3):767-780
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30476131
PMC ID: PMC6659358

Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium.

Cook MB,  Barnett MJ,  Bock CH,  Cross AJ,  Goodman PJ,  Goodman GE,  Haiman CA,  Khaw KT,  McCullough ML,  Newton CC,  Boutron-Ruault MC,  Lund E,  RutegÃ¥rd M,  Thornquist MD,  Spriggs M,  Giffen C,  Freedman ND,  Kemp T,  Kroenke CH,  Le Marchand L,  Park JY,  Simon M,  Wilkens LR,  Pinto L,  Hildesheim A,  Campbell PT
Gut 2019 Jun;68(6):960-968
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30121626
PMC ID: PMC6379150

Serum selenium and pancreatic cancer: a prospective study in the Prostate, Lung, Colorectal and Ovarian Cancer Trial cohort.

Chatterjee S,  Combs GF Jr,  Chattopadhyay A,  Stolzenberg-Solomon R
Cancer Causes Control 2019 May;30(5):457-464
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30915619
PMC ID: PMC6752711

Immune factors preceding diagnosis of glioma: a Prostate Lung Colorectal Ovarian Cancer Screening Trial nested case-control study.

Muskens IS,  Zhou M,  Mccoy L,  Bracci PM,  Hansen HM,  Gauderman WJ,  Wiencke JK,  Wrensch MR,  Wiemels JL
Neurooncol Adv 2019 May-Dec;1(1):vdz031
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31807733
PMC ID: PMC6881819

Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial.

Pinsky PF,  Miller E,  Prorok P,  Grubb R,  Crawford ED,  Andriole G
BJU Int 2019 May;123(5):854-860
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30288918
PMC ID: PMC6450783

MGS-Fast: Metagenomic shotgun data fast annotation using microbial gene catalogs.

Brown SM,  Chen H,  Hao Y,  Laungani BP,  Ali TA,  Dong C,  Lijeron C,  Kim B,  Wultsch C,  Pei Z,  Krampis K
Gigascience 2019 Apr 1;8(4)
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30942867
PMC ID: PMC6446249

Outcomes of Prostatectomy versus Radiation Therapy in the Management of Clinically Localized Prostate Cancer Patients Within the PLCO Trial.

Abdel-Rahman O
Clin Genitourin Cancer 2019 Apr;17(2):e329-e338
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30704795
PMC ID: not available

Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer.

Bien SA,  Su YR,  Conti DV,  Harrison TA,  Qu C,  Guo X,  Lu Y,  Albanes D,  Auer PL,  Banbury BL,  Berndt SI,  Bézieau S,  Brenner H,  Buchanan DD,  Caan BJ,  Campbell PT,  Carlson CS,  Chan AT,  Chang-Claude J,  Chen S,  Connolly CM,  Easton DF,  Feskens EJM,  Gallinger S,  Giles GG,  Gunter MJ,  Hampe J,  Huyghe JR,  Hoffmeister M,  Hudson TJ,  Jacobs EJ,  Jenkins MA,  Kampman E,  Kang HM,  Kühn T,  Küry S,  Lejbkowicz F,  Le Marchand L,  Milne RL,  Li L,  Li CI,  Lindblom A,  Lindor NM,  Martín V,  McNeil CE,  Melas M,  Moreno V,  Newcomb PA,  Offit K,  Pharaoh PDP,  Potter JD,  Qu C,  Riboli E,  Rennert G,  Sala N,  Schafmayer C,  Scacheri PC,  Schmit SL,  Severi G,  Slattery ML,  Smith JD,  Trichopoulou A,  Tumino R,  Ulrich CM,  van Duijnhoven FJB,  Van Guelpen B,  Weinstein SJ,  White E,  Wolk A,  Woods MO,  Wu AH,  Abecasis GR,  Casey G,  Nickerson DA,  Gruber SB,  Hsu L,  Zheng W,  Peters U
Hum Genet 2019 Apr;138(4):307-326
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30820706
PMC ID: PMC6483948

Vitamin K intake and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.

Hoyt M,  Reger M,  Marley A,  Fan H,  Liu Z,  Zhang J
Am J Clin Nutr 2019 Feb 1;109(2):392-401
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30624568
PMC ID: not available

Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial.

Pierre-Victor D,  Pinsky PF
JAMA Intern Med 2019 Feb 1;179(2):196-203
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30592477
PMC ID: PMC6439655

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.

Miller EA,  Pinsky PF,  Schoen RE,  Prorok PC,  Church TR
Lancet Gastroenterol Hepatol 2019 Feb;4(2):101-110
Major Program(s) or Research Group(s): Early Detection ;  Office of the Director ;  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30502933
PMC ID: PMC6335177

Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men.

Petrick JL,  Hyland PL,  Caron P,  Falk RT,  Pfeiffer RM,  Dawsey SM,  Abnet CC,  Taylor PR,  Weinstein SJ,  Albanes D,  Freedman ND,  Gapstur SM,  Bradwin G,  Guillemette C,  Campbell PT,  Cook MB
J Natl Cancer Inst 2019 Jan 1;111(1):34-41
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29788475
PMC ID: PMC6335110

Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Butt J,  Varga MG,  Blot WJ,  Teras L,  Visvanathan K,  Le Marchand L,  Haiman C,  Chen Y,  Bao Y,  Sesso HD,  Wassertheil-Smoller S,  Ho GYF,  Tinker LE,  Peek RM,  Potter JD,  Cover TL,  Hendrix LH,  Huang LC,  Hyslop T,  Um C,  Grodstein F,  Song M,  Zeleniuch-Jacquotte A,  Berndt S,  Hildesheim A,  Waterboer T,  Pawlita M,  Epplein M
Gastroenterology 2019 Jan;156(1):175-186.e2
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30296434
PMC ID: PMC6309494

Discovery of common and rare genetic risk variants for colorectal cancer.

Huyghe JR,  Bien SA,  Harrison TA,  Kang HM,  Chen S,  Schmit SL,  Conti DV,  Qu C,  Jeon J,  Edlund CK,  Greenside P,  Wainberg M,  Schumacher FR,  Smith JD,  Levine DM,  Nelson SC,  Sinnott-Armstrong NA,  Albanes D,  Alonso MH,  Anderson K,  Arnau-Collell C,  Arndt V,  Bamia C,  Banbury BL,  Baron JA,  Berndt SI,  Bézieau S,  Bishop DT,  Boehm J,  Boeing H,  Brenner H,  Brezina S,  Buch S,  Buchanan DD,  Burnett-Hartman A,  Butterbach K,  Caan BJ,  Campbell PT,  Carlson CS,  Castellví-Bel S,  Chan AT,  Chang-Claude J,  Chanock SJ,  Chirlaque MD,  Cho SH,  Connolly CM,  Cross AJ,  Cuk K,  Curtis KR,  de la Chapelle A,  Doheny KF,  Duggan D,  Easton DF,  Elias SG,  Elliott F,  English DR,  Feskens EJM,  Figueiredo JC,  Fischer R,  FitzGerald LM,  Forman D,  Gala M,  Gallinger S,  Gauderman WJ,  Giles GG,  Gillanders E,  Gong J,  Goodman PJ,  Grady WM,  Grove JS,  Gsur A,  Gunter MJ,  Haile RW,  Hampe J,  Hampel H,  Harlid S,  Hayes RB,  Hofer P,  Hoffmeister M,  Hopper JL,  Hsu WL,  Huang WY,  Hudson TJ,  Hunter DJ,  Ibañez-Sanz G,  Idos GE,  Ingersoll R,  Jackson RD,  Jacobs EJ,  Jenkins MA,  Joshi AD,  Joshu CE,  Keku TO,  Key TJ,  Kim HR,  Kobayashi E,  Kolonel LN,  Kooperberg C,  Kühn T,  Küry S,  Kweon SS,  Larsson SC,  Laurie CA,  Le Marchand L,  Leal SM,  Lee SC,  Lejbkowicz F,  Lemire M,  Li CI,  Li L,  Lieb W,  Lin Y,  Lindblom A,  Lindor NM,  Ling H,  Louie TL,  Männistö S,  Markowitz SD,  Martín V,  Masala G,  McNeil CE,  Melas M,  Milne RL,  Moreno L,  Murphy N,  Myte R,  Naccarati A,  Newcomb PA,  Offit K,  Ogino S,  Onland-Moret NC,  Pardini B,  Parfrey PS,  Pearlman R,  Perduca V,  Pharoah PDP,  Pinchev M,  Platz EA,  Prentice RL,  Pugh E,  Raskin L,  Rennert G,  Rennert HS,  Riboli E,  Rodríguez-Barranco M,  Romm J,  Sakoda LC,  Schafmayer C,  Schoen RE,  Seminara D,  Shah M,  Shelford T,  Shin MH,  Shulman K,  Sieri S,  Slattery ML,  Southey MC,  Stadler ZK,  Stegmaier C,  Su YR,  Tangen CM,  Thibodeau SN,  Thomas DC,  Thomas SS,  Toland AE,  Trichopoulou A,  Ulrich CM,  Van Den Berg DJ,  van Duijnhoven FJB,  Van Guelpen B,  van Kranen H,  Vijai J,  Visvanathan K,  Vodicka P,  Vodickova L,  Vymetalkova V,  Weigl K,  Weinstein SJ,  White E,  Win AK,  Wolf CR,  Wolk A,  Woods MO,  Wu AH,  Zaidi SH,  Zanke BW,  Zhang Q,  Zheng W,  Scacheri PC,  Potter JD,  Bassik MC,  Kundaje A,  Casey G,  Moreno V,  Abecasis GR,  Nickerson DA,  Gruber SB,  Hsu L,  Peters U
Nat Genet 2019 Jan;51(1):76-87
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30510241
PMC ID: PMC6358437

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study.

Johansson M,  Carreras-Torres R,  Scelo G,  Purdue MP,  Mariosa D,  Muller DC,  Timpson NJ,  Haycock PC,  Brown KM,  Wang Z,  Ye Y,  Hofmann JN,  Foll M,  Gaborieau V,  Machiela MJ,  Colli LM,  Li P,  Garnier JG,  Blanche H,  Boland A,  Burdette L,  Prokhortchouk E,  Skryabin KG,  Yeager M,  Radojevic-Skodric S,  Ognjanovic S,  Foretova L,  Holcatova I,  Janout V,  Mates D,  Mukeriya A,  Rascu S,  Zaridze D,  Bencko V,  Cybulski C,  Fabianova E,  Jinga V,  Lissowska J,  Lubinski J,  Navratilova M,  Rudnai P,  Benhamou S,  Cancel-Tassin G,  Cussenot O,  Weiderpass E,  Ljungberg B,  Tumkur Sitaram R,  Häggström C,  Bruinsma F,  Jordan SJ,  Severi G,  Winship I,  Hveem K,  Vatten LJ,  Fletcher T,  Larsson SC,  Wolk A,  Banks RE,  Selby PJ,  Easton DF,  Andreotti G,  Beane Freeman LE,  Koutros S,  Männistö S,  Weinstein S,  Clark PE,  Edwards TL,  Lipworth L,  Gapstur SM,  Stevens VL,  Carol H,  Freedman ML,  Pomerantz MM,  Cho E,  Wilson KM,  Gaziano JM,  Sesso HD,  Freedman ND,  Parker AS,  Eckel-Passow JE,  Huang WY,  Kahnoski RJ,  Lane BR,  Noyes SL,  Petillo D,  Teh BT,  Peters U,  White E,  Anderson GL,  Johnson L,  Luo J,  Buring J,  Lee IM,  Chow WH,  Moore LE,  Eisen T,  Henrion M,  Larkin J,  Barman P,  Leibovich BC,  Choueiri TK,  Lathrop GM,  Deleuze JF,  Gunter M,  McKay JD,  Wu X,  Houlston RS,  Chanock SJ,  Relton C,  Richards JB,  Martin RM,  Davey Smith G,  Brennan P
PLoS Med 2019 Jan;16(1):e1002724
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30605491
PMC ID: PMC6317776

Combined effect of modifiable and non-modifiable risk factors for colorectal cancer risk in a pooled analysis of 11 population-based studies.

Wang X,  O'Connell K,  Jeon J,  Song M,  Hunter D,  Hoffmeister M,  Lin Y,  Berndt S,  Brenner H,  Chan AT,  Chang-Claude J,  Gong J,  Gunter MJ,  Harrison TA,  Hayes RB,  Joshi A,  Newcomb P,  Schoen R,  Slattery ML,  Vargas A,  Potter JD,  Le Marchand L,  Giovannucci E,  White E,  Hsu L,  Peters U,  Du M
BMJ Open Gastroenterol 2019;6(1):e000339
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 31875139
PMC ID: PMC6904202

Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.

Yang L,  Hao Y,  Hu J,  Kelly D,  Li H,  Brown S,  Tasker C,  Roche NE,  Chang TL,  Pei Z
Emerg Microbes Infect 2019;8(1):197-210
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30866773
PMC ID: PMC6455113

AA9int: SNP interaction pattern search using non-hierarchical additive model set.

Lin HY,  Huang PY,  Chen DT,  Tung HY,  Sellers TA,  Pow-Sang JM,  Eeles R,  Easton D,  Kote-Jarai Z,  Amin Al Olama A,  Benlloch S,  Muir K,  Giles GG,  Wiklund F,  Gronberg H,  Haiman CA,  Schleutker J,  Nordestgaard BG,  Travis RC,  Hamdy F,  Neal DE,  Pashayan N,  Khaw KT,  Stanford JL,  Blot WJ,  Thibodeau SN,  Maier C,  Kibel AS,  Cybulski C,  Cannon-Albright L,  Brenner H,  Kaneva R,  Batra J,  Teixeira MR,  Pandha H,  Lu YJ,  PRACTICAL Consortium,  Park JY
Bioinformatics 2018 Dec 15;34(24):4141-4150
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29878078
PMC ID: PMC6289141

Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3).

Larose TL,  Guida F,  Fanidi A,  Langhammer A,  Kveem K,  Stevens VL,  Jacobs EJ,  Smith-Warner SA,  Giovannucci E,  Albanes D,  Weinstein SJ,  Freedman ND,  Prentice R,  Pettinger M,  Thomson CA,  Cai Q,  Wu J,  Blot WJ,  Arslan AA,  Zeleniuch-Jacquotte A,  Le Marchand L,  Wilkens LR,  Haiman CA,  Zhang X,  Stampfer MJ,  Hodge AM,  Giles GG,  Severi G,  Johansson M,  Grankvist K,  Wang R,  Yuan JM,  Gao YT,  Koh WP,  Shu XO,  Zheng W,  Xiang YB,  Li H,  Lan Q,  Visvanathan K,  Hoffman Bolton J,  Ueland PM,  Midttun Ø,  Caporaso N,  Purdue M,  Sesso HD,  Buring JE,  Lee IM,  Gaziano JM,  Manjer J,  Brunnström H,  Brennan P,  Johansson M
Int J Epidemiol 2018 Dec 1;47(6):1760-1771
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29901778
PMC ID: PMC6280953

Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Xu Y,  Liu H,  Liu S,  Wang Y,  Xie J,  Stinchcombe TE,  Su L,  Zhang R,  Christiani DC,  Li W,  Wei Q
Int J Cancer 2018 Nov 15;143(10):2400-2408
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 29978465
PMC ID: PMC6205899

Germline variation at 8q24 and prostate cancer risk in men of European ancestry.

Matejcic M,  Saunders EJ,  Dadaev T,  Brook MN,  Wang K,  Sheng X,  Olama AAA,  Schumacher FR,  Ingles SA,  Govindasami K,  Benlloch S,  Berndt SI,  Albanes D,  Koutros S,  Muir K,  Stevens VL,  Gapstur SM,  Tangen CM,  Batra J,  Clements J,  Gronberg H,  Pashayan N,  Schleutker J,  Wolk A,  West C,  Mucci L,  Kraft P,  Cancel-Tassin G,  Sorensen KD,  Maehle L,  Grindedal EM,  Strom SS,  Neal DE,  Hamdy FC,  Donovan JL,  Travis RC,  Hamilton RJ,  Rosenstein B,  Lu YJ,  Giles GG,  Kibel AS,  Vega A,  Bensen JT,  Kogevinas M,  Penney KL,  Park JY,  Stanford JL,  Cybulski C,  Nordestgaard BG,  Brenner H,  Maier C,  Kim J,  Teixeira MR,  Neuhausen SL,  De Ruyck K,  Razack A,  Newcomb LF,  Lessel D,  Kaneva R,  Usmani N,  Claessens F,  Townsend PA,  Gago-Dominguez M,  Roobol MJ,  Menegaux F,  Khaw KT,  Cannon-Albright LA,  Pandha H,  Thibodeau SN,  Schaid DJ,  PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium,  Wiklund F,  Chanock SJ,  Easton DF,  Eeles RA,  Kote-Jarai Z,  Conti DV,  Haiman CA
Nat Commun 2018 Nov 5;9(1):4616
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening TrialNCI Community Oncology Research Program
PubMed ID: 30397198
PMC ID: PMC6218483

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.

McMaster ML,  Berndt SI,  Zhang J,  Slager SL,  Li SA,  Vajdic CM,  Smedby KE,  Yan H,  Birmann BM,  Brown EE,  Smith A,  Kleinstern G,  Fansler MM,  Mayr C,  Zhu B,  Chung CC,  Park JH,  Burdette L,  Hicks BD,  Hutchinson A,  Teras LR,  Adami HO,  Bracci PM,  McKay J,  Monnereau A,  Link BK,  Vermeulen RCH,  Ansell SM,  Maria A,  Diver WR,  Melbye M,  Ojesina AI,  Kraft P,  Boffetta P,  Clavel J,  Giovannucci E,  Besson CM,  Canzian F,  Travis RC,  Vineis P,  Weiderpass E,  Montalvan R,  Wang Z,  Yeager M,  Becker N,  Benavente Y,  Brennan P,  Foretova L,  Maynadie M,  Nieters A,  de Sanjose S,  Staines A,  Conde L,  Riby J,  Glimelius B,  Hjalgrim H,  Pradhan N,  Feldman AL,  Novak AJ,  Lawrence C,  Bassig BA,  Lan Q,  Zheng T,  North KE,  Tinker LF,  Cozen W,  Severson RK,  Hofmann JN,  Zhang Y,  Jackson RD,  Morton LM,  Purdue MP,  Chatterjee N,  Offit K,  Cerhan JR,  Chanock SJ,  Rothman N,  Vijai J,  Goldin LR,  Skibola CF,  Caporaso NE
Nat Commun 2018 Oct 10;9(1):4182
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30305637
PMC ID: PMC6180091

Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer.

Agalliu I,  Chen Z,  Wang T,  Hayes RB,  Freedman ND,  Gapstur SM,  Burk RD
Cancer Epidemiol Biomarkers Prev 2018 Oct;27(10):1168-1175
Major Program(s) or Research Group(s): Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30087123
PMC ID: PMC6170688

The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.

Miller EA,  Pinsky PF,  Pierre-Victor D
Cancer Causes Control 2018 Oct;29(10):907-914
Major Program(s) or Research Group(s): Cancer Prevention Fellowship ProgramEarly DetectionProstate, Lung, Colorectal, and Ovarian Cancer Screening Trial
PubMed ID: 30094676
PMC ID: not available